Alector (ALEC) EBT Margin (2018 - 2026)

Alector (ALEC) posted quarterly EBT Margin of 2192.16% for Q1 2026, down 109061.0% year-over-year from N/an in Q1 2025, and down 268.54% quarter-over-quarter from 594.82% in Q4 2025.

Alector (ALEC) EBT Margin (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported EBT Margin for 9 consecutive years, with 2192.16% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin fell 109061.0% year-over-year to 2192.16%; the TTM figure through Mar 2026 stood at 679.92% (down 54032.0% YoY), while the FY2025 annual figure was 678.36%, down 56010.0% from the prior year.
  • EBT Margin eased to 2192.16% in Q1 2026 per ALEC's latest filing, from 594.82% in the prior quarter.
  • Across five years, EBT Margin topped out at 13.68% in Q2 2022 and bottomed at 2192.16% in Q1 2026.
  • Historically, EBT Margin has averaged 466.7% across 5 years, with a median of 275.19% in 2024.
  • Annual changes were most pronounced in 2022 — EBT Margin jumped 109016 bps — and 2026, when it sank 109061 bps.
  • Alector's EBT Margin stood at 358.08% in 2022, then gained by 27 bps to 261.8% in 2023, then jumped by 99 bps to 3.74% in 2024, then plunged by 15825 bps to 594.82% in 2025, then slumped by 269 bps to 2192.16% in 2026.
  • Business Quant data shows ALEC's EBT Margin at 2192.16% in Q1 2026, 594.82% in Q4 2025, and 1063.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Alector 218.85 Mn 46.05 Mn - -688.55%

Historic Data

Download Data
DateValue
Jun 30, 2026 -688.55%
Mar 31, 2026 -2,192.16%
Dec 31, 2025 -594.82%
Sep 30, 2025 -1,063.40%
Jun 30, 2025 -387.66%
Mar 31, 2025 -1,101.55%
Dec 31, 2024 -3.74%
Sep 30, 2024 -275.19%
Jun 30, 2024 -255.94%
Mar 31, 2024 -226.97%
Dec 31, 2023 -261.80%
Sep 30, 2023 -474.51%
Jun 30, 2023 4.92%
Mar 31, 2023 -271.65%
Dec 31, 2022 -358.08%
Sep 30, 2022 -305.78%
Jun 30, 2022 13.68%
Mar 31, 2022 -179.21%
Dec 31, 2021 -397.37%
Sep 30, 2021 69.40%